PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Purified gambir (90% catechin) lowered plasma MDA and TNF-α levels in alloxan-induced diabetic rats [PMID:38266537]; other studies showed antidiabetic activity in Sprague-Dawley rats [PMID:40035273] and improved glucose uptake in 3T3-L1 cells [PMID:33072538].
Exhibited antifibrotic effects in bleomycin-induced fibrosis rat models [PMID:35795272].
Extract at 80 mg/kg BW reduced TNF-alpha levels and lesion area while increasing prostaglandin E2 in Wistar rat models [PMID:31949507].
A bioactive fraction (DLBS1Y62) showed antidiarrheal effects in castor oil-induced diarrhea rat models [PMID:34290534].
Nano-encapsulated U. gambir demonstrated anti-cancer and chemopreventive effects against T47D cells and in benzo[a]pyrene-induced breast cancer mice [PMID:37555190].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36235088 (2022) — Current Research of Phytochemical, Medicinal and Non-Medicinal Uses of Uncaria gambir Roxb.: A Review. · Molecules (Basel, Switzerland)
- 2.PMID: 38266537 (2024) — Malondialdehyde and TNF-α lowering effects of purified gambier (Uncaria gambir Roxb.) in diabetic rats. · Journal of Ayurveda and integrative medicine
- 3.PMID: 37555190 (2023) — Nano Uncaria gambir as Chemopreventive Agent Against Breast Cancer. · International journal of nanomedicine
- 4.PMID: 35795272 (2022) — Fibropreventive and Antifibrotic Effects of Uncaria gambir on Rats with Pulmonary Fibrosis. · Evidence-based complementary and alternative medicine : eCAM
- 5.PMID: 41716185 (2025)